CNBCLean R·
Novo shares slide as drugmaker lays out post-Wegovy growth strategy
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
Read at CNBC →
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
<iframe src="https://statesidedaily.com/embed/cluster/f9e120fd7a1c04e7d01533c4274f8e3f60b6144a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novo shares slide as drugmaker lays out post-Wegovy growth strategy"></iframe>